Scholarly Index
Haitao Zhao
Chinese Academy of Medical Sciences & Peking Union Medical College; 14,574 total citations; 466 total publications; best world rank #9
Chinese Academy of Medical Sciences & Peking Union Medical College
14,574Total citations
466Total publications
59H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 336 | CN 23 | 98.52 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 718 | CN 67 | 97.92 |
| Cancer Mechanisms and Therapy | Lifetime | 416 | CN 62 | 95.90 |
| Ferroptosis and cancer prognosis | Lifetime | 649 | CN 363 | 94.10 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 624 | CN 112 | 91.08 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 17 | CN 3 | 99.53 |
| Cancer Mechanisms and Therapy | 2021-2025 | 9 | CN 4 | 98.91 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 63 | CN 15 | 99.01 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 333 | CN 37 | 97.27 |
| Peptidase Inhibition and Analysis | 2021-2025 | 148 | CN 36 | 96.56 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 878 | CN 193 | 96.58 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 348 | CN 11 | 94.37 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 462 | CN 45 | 91.48 |
| Renal cell carcinoma treatment | 2021-2025 | 989 | CN 148 | 87.78 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 966 | CN 401 | 83.65 |